ALHC vs. SWTX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALHC and SWTX, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With ALHC at 3.03 billion USD and SWTX at 3.48 billion USD, their market capitalizations sit in the same ballpark.
ALHC’s beta of 1.33 points to much larger expected swings compared to SWTX’s calmer 0.77, suggesting both higher upside and downside potential.
| Symbol | ALHC | SWTX |
|---|---|---|
| Company Name | Alignment Healthcare, Inc. | SpringWorks Therapeutics, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Healthcare Plans | Biotechnology |
| CEO | Mr. John E. Kao | Mr. Saqib Islam J.D. |
| Price | 15.33 USD | 46.21 USD |
| Market Cap | 3.03 billion USD | 3.48 billion USD |
| Beta | 1.33 | 0.77 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | March 26, 2021 | September 13, 2019 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALHC and SWTX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ALHC and SWTX based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- Neither ALHC nor SWTX turned a profit—both carry negative P/E ratios of -32.75 and -13.63, underscoring continued losses that pressure their valuations.
- Analysts assign negative forward PEG ratios to both ALHC (-1.11) and SWTX (-6.77), suggesting expectation of shrinking or negative earnings in the upcoming period—a worrying sign for their profit outlook.
- SWTX reports a negative Price-to-Free Cash Flow ratio of -19.97, showing a cash flow shortfall that could threaten its operational sustainability, while ALHC at 159.00 maintains positive cash flow.
| Symbol | ALHC | SWTX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | -32.75 | -13.63 |
| Forward PEG Ratio (TTM) | -1.11 | -6.77 |
| Price-to-Sales Ratio (P/S, TTM) | 1.01 | 15.84 |
| Price-to-Book Ratio (P/B, TTM) | 27.45 | 8.29 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 159.00 | -19.97 |
| EV-to-EBITDA (TTM) | -64.47 | -13.07 |
| EV-to-Sales (TTM) | 0.86 | 15.59 |
| EV-to-Free Cash Flow (TTM) | 136.01 | -19.64 |
Dividend Comparison
Neither ALHC nor SWTX currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALHC | SWTX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALHC and SWTX, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- With negative EBIT (-2.98), ALHC cannot cover its interest payments. SWTX, with an interest coverage of 265.27, meets its interest obligations.
| Symbol | ALHC | SWTX |
|---|---|---|
| Current Ratio (TTM) | 1.69 | 4.33 |
| Quick Ratio (TTM) | 1.69 | 4.18 |
| Debt-to-Equity Ratio (TTM) | 0.07 | 0.02 |
| Debt-to-Assets Ratio (TTM) | 0.01 | 0.01 |
| Interest Coverage Ratio (TTM) | -2.98 | 265.27 |